Cancer Blog
- Dr. Robert Nagourney -

I’ve long held that there are no bad cancers, just cancers that we can or cannot treat.

The PET scan revealed progressive disease associated with chest pain, and she restarted the low-dose chemotherapy that had proven effective

Daniel Werner, a dedicated nurse and a loving fiancé and father, faced the grim reality of a stage 4 colon cancer diagnosis in December 2021

This patient had recurrent breast cancer that upon biopsy proved to be triple negative.

At the 2023 American Association for Cancer Research meeting in Orlando, we reported results of ex vivo analysis of programmed cell death.

He has outlived cancer for over 16 years. To our knowledge one of the longest-living stage 4 cancer survivors from the armed forces.

The results showed that all the drugs the other doctors recommended, paclitaxel, cisplatin, gemcitabine... would have been ineffective.

The information he received from the functional profile helped him find the right treatment regimen to save his life.

My oncologist said that the results were remarkable and that I chose the right drugs based on Dr. Nagourney's testing.

Do your homework. Take charge of your care and don’t let anyone push you around. I took charge and I’m doing great 15 years later.

After a review of the options, Dr. Nagourney explained that her highly favorable drug sensitivity profile suggested strong drug combonations

Dr. Robert Nagourney was interviewed on the show “Extra”. He is having higher than normal results in treating cancer, with good outcomes.

The assay found that many of the standard chemotherapies would have been ineffective in killing Jeff’s cancer.

An endoscopic exam with biopsy confirmed that Ken had Stage 4 pancreatic cancer that had spread to his liver.

Within 11 days, Brittany's tryptase level went from high 100's, and over 200 in the end of October, to 24.

I am a 48-year-old male, who experienced sharp abdominal pain and a visit to the ER, was diagnosed with metastatic Stage 4 stomach cancer.

Rational Therapeutics diagnosed me with Waldenstrom’s Macroglobulinemia, a rare form of Non-Hodgkin Lymphoma.

He explained the basis for his approach was to obtain a sample of the cancerous tissue and test a wide variety of cancer drugs against it.

After undergoing a mammogram, ultrasound, MRI, CT Scan, PET Scan and a biopsy, I was told that I had a very aggressive kind of cancer.

He identified excellent activity for a two-drug combination that he had previously used successfully in ovarian, breast, and cervical cancer